Publications by authors named "Alexandre Willaume"

Introduction: The first-step in diagnosis of myelodysplastic neoplasms (MDS) is essentially based on bone marrow cytomorphology. However, cytomorphology of MDS is often a difficult exercise, subject to inter-operator variability. Our study aims to evaluate whether the combination of two dysplasia scores, the extended Ogata score and the MDS-CBC score, could improve the screening of MDS patients among patients with chronic cytopenia.

View Article and Find Full Text PDF
Article Synopsis
  • * Out of 75 patients with successful BCR expression, a significant majority had mutated immunoglobulin heavy chains (IgVH), and a subgroup of 12 patients showed a highly dominant BCR clone associated with worse clinical outcomes.
  • * The results indicated that high clonal dominance correlates with reduced BCR diversity and increased expression of specific genes, leading to poorer progression-free survival (PFS) and overall survival (OS) rates, corroborated by an independent patient cohort analysis.
View Article and Find Full Text PDF
Article Synopsis
  • Primary mediastinal B-cell lymphoma (PMBL) is a rare but aggressive form of lymphoma that typically has a good prognosis, although 10-15% of cases are resistant to chemotherapy.
  • Researchers studied a group of 120 patients to identify which ones might be at higher risk for poor outcomes using gene expression profiling.
  • Their findings showed that high expression of the genes PDL1 and PDL2 is linked to worse survival rates, suggesting that these patients may need alternative treatments like checkpoint inhibitors instead of standard chemotherapy.
View Article and Find Full Text PDF

Objectives: New PET data-processing tools allow for automatic lesion selection and segmentation by a convolution neural network using artificial intelligence (AI) to obtain total metabolic tumor volume (TMTV) and total lesion glycolysis (TLG) routinely at the clinical workstation. Our objective was to evaluate an AI implemented in a new version of commercial software to verify reproducibility of results and time savings in a daily workflow.

Methods: Using the software to obtain TMTV and TLG, two nuclear physicians applied five methods to retrospectively analyze data for 51 patients.

View Article and Find Full Text PDF
Article Synopsis
  • Primary mediastinal B-cell lymphoma (PMBL) predominantly affects young females and has an unclear first-line treatment standard, prompting a large study across 25 centers in France and Belgium to assess patient outcomes.
  • The study included 313 patients treated with different regimens (R-ACVBP and R-CHOP) and found comparable end-of-treatment metabolic response rates, although R-ACVBP showed higher toxicity like febrile neutropenia and mucositis.
  • Results indicated three-year progression-free survival rates of 89.4% for both R-ACVBP and R-CHOP14, while R-CHOP21 was lower at 74.7%; a higher baseline tumor volume was linked
View Article and Find Full Text PDF

Background And Purpose: During the COVID-19 outbreak, the presence of extensive white matter microhemorrhages was detected by brain MRIs. The goal of this study was to investigate the origin of this atypical hemorrhagic complication.

Methods: Between March 17 and May 18, 2020, 80 patients with severe COVID-19 infections were admitted for acute respiratory distress syndrome to intensive care units at the University Hospitals of Strasbourg for whom a brain MRI for neurologic manifestations was performed.

View Article and Find Full Text PDF

The selenoprotein glutathione peroxidase 4 (GPX4), the only member of the glutathione peroxidase family able to directly reduce cell membrane-oxidized fatty acids and cholesterol, was recently identified as the central regulator of ferroptosis. GPX4 knockdown in mouse hematopoietic cells leads to hemolytic anemia and to increased spleen erythroid progenitor death. The role of GPX4 during human erythropoiesis is unknown.

View Article and Find Full Text PDF

Objectives: Antibiotics for febrile neutropenia (FN) in acute myeloid leukaemia (AML) patients undergoing intensive chemotherapy are usually maintained until neutropenia resolution, because of the risk of uncontrolled sepsis in this vulnerable population. This leads to unnecessarily prolonged antimicrobial therapy.

Methods: Based on ECIL-4 recommendations, we modified our management strategy and discontinued antibiotics after a pre-established duration in patients treated for a first episode of FN between August 2014 and October 2017.

View Article and Find Full Text PDF

Multiple Myeloma (MM) is an incurable disease characterized by a clonal evolution across the course of the diseases and multiple lines of treatment. Among genomic drivers of the disease, alterations of the tumor suppressor are associated with poor outcomes. In physiological situation, once activated by oncogenic stress or DNA damage, p53 induces either cell-cycle arrest or apoptosis depending on the cellular context.

View Article and Find Full Text PDF